Table 1 PRO labeling claims by type of claim (2000-2012)
From: Potential of patient-reported outcomes as nonprimary endpoints in clinical trials
Type of claim (N = 83) | Products with PRO claim (N = 70) | |
|---|---|---|
Number of claims | Percentage of claims | |
Signs and symptoms | 59 | 84 |
Functioning | 13 | 19 |
HRQOL | 3 | 4 |
Patient global rating | 3 | 4 |
Other | 5 | 7 |